Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
Open accessThe DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
Abstract
Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones and Michael Horowitz
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Relationship between the effect of exenatide subcutaneously twice a day for 5 days on postprandial glycemia (plasma glucose area under the curve (AUC) [0–3 h]) and gastric emptying (50% emptying [t50]) of a radiolabeled solid meal in type 2 diabetic patients (n = 17). Placebo, white circles; 5 μg exenatide, black triangles; and 10 μg exenatide, black squares. R = −0.49, P < 0.0001. A longer t50 is indicative of slower gastric emptying. Reprinted with permission from Linnebjerg et al. (64).](https://figures.cochat.ai/paper-figures/82537632150741ada68ecc10248a423e/relationships-between-gastric-emptying-postprandial-glycemia-and-incretin-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, GLP-1 can reduce blood glucose production by delaying gastric emptying and decreasing appetite, which also contributes to overall blood glucose control.239,240”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [240]
Experimental — accuracy not yet measuredIn the citing paper
“and are determined by meal composition, the rate of gastric emptying, hepatic and peripheral glucose metabolism, intestinal glucose absorption, and insulin secretion and resistance (63).”
From Gut mechanisms linking intestinal sweet sensing to glycemic control (2018) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · cited 4×
“with type 2 diabetes, the magnitude of GLP-1 response is likely to be crucial given the reduced insulinotropic effect ofGIP (7).”
BackgroundInfluentialBiology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 4×
“like peptide-1(7-36)amide on antro-pyloro-”
BackgroundInfluentialManagement of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 1×
“(2) indicating that in type 2 diabetes, postprandial glycemic excursions account for about 70% of variability when HbA1c is ,7.”
BackgroundBeneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus
Chandalia, M., Garg, A., Lutjohann, D., von Bergmann, K., Grundy, S. M., & Brinkley, L. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421903 · Cited by 1,129
Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070
Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R., & Schmiegel, W. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 817
Jung, H., Choung, R. S., Locke, G. R., Schleck, C. D., Zinsmeister, A. R., Szarka, L. A., Mullan, B., & Talley, N. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.047 · Cited by 571
Kolterman, O. G., Buse, J. B., Fineman, M. S., Gaines, E., Heintz, S., Bicsak, T. A., Taylor, K., Kim, D., Aisporna, M., Wang, Y., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021545 · Cited by 552
Research works printed but not linked: 1
- Marathe, 2012;, The size of incretin effect is dependent upon the small intestinal glucose load, Diabetes, A
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“239,240 In summary, GLP-1 lowers blood glucose levels and inhibits glucagon secretion through direct action on α -cells, promotion of insulin secretion, and regulation of gastrointestinal activity.”
BackgroundSteinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Self-citationMicrobiota and metabolic diseases
Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Gastric emptying and glycaemia in health and diabetes mellitus
Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.202 · Cited by 273
Self-citationHjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13120 · Cited by 245
“suppress glucagon and slow gastric emptying, which affects the postprandial glucose response.(13,14,19) The observed reduction in postprandial insulin and C-peptide in this trial may be explained, in part, by the reduction in glucose concentrations observed after 12 weeks of treatment.”
BackgroundResultInfluentialDimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
“The rates of gastric emptying and intestinal glucose absorption determine the feedback relationship between the increases in blood glucose levels and insulin secretion, and therefore play a decisive role in the magnitude of postprandial hyperglycemia and hyperinsulinemia [176].”
BackgroundCavin, J.-B., Couvelard, A., Lebtahi, R., Ducroc, R., Arapis, K., Voitellier, E., Cluzeaud, F., Gillard, L., Hourseau, M., Mikail, N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.10.009 · Cited by 220
Færch, K., Vistisen, D., Pacini, G., Torekov, S. S., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., et al. (2016) · Diabetes · doi:10.2337/db16-0240 · Cited by 217
“However, the negative-feedback mechanism, which limits the amount of nutrients released into the bloodstream during hyperglycemic states (31) makes it difficult to conclude whether delayed gastric emptying results in delayed glucagon suppression or whether a worsening of early glucagon suppression with resulting hyper…”
BackgroundPapakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
“(d) The gastrointestinal tract plays a significant role in the regulation of hyperglycemia during food ingestion via feedback mechanisms coordinated by the CNS [62].”
BackgroundInfluentialBeta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Wysham, C., & Shubrook, J. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1771047 · Cited by 193
Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia
Chávez-Reyes, J., Escárcega-González, C. E., Chavira-Suárez, E., León-Buitimea, A., Vázquez-León, P., Morones-Ramírez, J. R., Villalón, C. M., Quintanar-Stephano, A., & Marichal-Cancino, B. A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.559595 · Cited by 181
Bossart, M., Wagner, M., Elvert, R., Evers, A., Hübschle, T., Kloeckener, T., Lorenz, K., Moessinger, C., Eriksson, O., Velikyan, I., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.005 · Cited by 179
Semaglutide as a promising antiobesity drug
Christou, G. A., Katsiki, N., Blundell, J., Fruhbeck, G., & Kiortsis, D. N. (2019) · Obesity Reviews · doi:10.1111/obr.12839 · Cited by 159
“Gastric emptying can also be delayed following semaglutide administration.(46) Apart from glucose lowering, semaglutide promotes weight loss.”
BackgroundRoles of the gut in the metabolic syndrome: an overview
Fändriks, L. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12584 · Cited by 144
van Zuylen, M. L., Siegelaar, S. E., Plummer, M. P., Deane, A. M., Hermanides, J., & Hulst, A. H. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.01.001 · Cited by 132
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia
Craig, C. M., Liu, L.-F., Deacon, C. F., Holst, J. J., & McLaughlin, T. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4179-x · Cited by 120
Kapitza, C., Dahl, K., Jacobsen, J. B., Axelsen, M. B., & Flint, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4289-0 · Cited by 117
Wopereis, S., Stroeve, J. H. M., Stafleu, A., Bakker, G. C. M., Burggraaf, J., van Erk, M. J., Pellis, L., Boessen, R., Kardinaal, A. A. F., & van Ommen, B. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0570-6 · Cited by 129
Gil-Lozano, M., Hunter, P. M., Behan, L.-A., Gladanac, B., Casper, R. F., & Brubaker, P. L. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2015 · Cited by 114
Abu Dayyeh, B. K., Maselli, D. B., Rapaka, B., Lavin, T., Noar, M., Hussan, H., Chapman, C. G., Popov, V., Jirapinyo, P., Acosta, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02394-1 · Cited by 109
Gharibans, A. A., Calder, S. S., Varghese, C., Waite, S. J., Schamberg, G., Daker, C., Du, P., Alighaleh, S., Carson, D. A., Woodhead, J. S. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq3544 · Cited by 106
Comerford, K., & Pasin, G. (2016) · Nutrients · doi:10.3390/nu8080446 · Cited by 107
Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity
Jensterle, M., Ferjan, S., Ležaič, L., Sočan, A., Goričar, K., Zaletel, K., & Janez, A. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14944 · Cited by 102
Hiramoto, B., McCarty, T. R., Lodhia, N. A., Jenkins, A., Elnaiem, A., Muftah, M., Flanagan, R., & Chan, W. W. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002820 · Cited by 94
Watson, L. E., Xie, C., Wang, X., Li, Z., Phillips, L. K., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02736 · Cited by 99
Self-citationMarathe, C. S., Horowitz, M., Trahair, L. G., Wishart, J. M., Bound, M., Lange, K., Rayner, C. K., & Jones, K. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2482 · Cited by 97
Self-citationCarbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes
Shukla, A. P., Andono, J., Touhamy, S. H., Casper, A., Iliescu, R. G., Mauer, E., Shan Zhu, Y., Ludwig, D. S., & Aronne, L. J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000440 · Cited by 96
Mat, D. J. L., Cattenoz, T., Souchon, I., Michon, C., & Feunteun, S. L. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.06.115 · Cited by 101
Whey protein: The “whey” forward for treatment of type 2 diabetes?
Mignone, L. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i14.1274 · Cited by 90
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives
Stevens, J. E., Jones, K. L., Rayner, C. K., & Horowitz, M. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.795948 · Cited by 88
Self-citationJunker, A. E., Gluud, L., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12462 · Cited by 88
Dahl, K., Brooks, A., Almazedi, F., Hoff, S. T., Boschini, C., & Bækdal, T. A. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14373 · Cited by 87
“This has been linked to the reduction in postprandial hyperglycaemia, and so may be one of the mechanisms by which these drugs improve glycaemic control.(34) We found that oral semaglutide delayed gastric emptying during the first hour compared with placebo, but total paracetamol absorption over 5 h after ingestion wa…”
ResultPerano, S. J., Couper, J. J., Horowitz, M., Martin, A. J., Kritas, S., Sullivan, T., & Rayner, C. K. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4417 · Cited by 87
Self-citationMetoclopramide for the treatment of diabetic gastroparesis
Shakhatreh, M., Jehangir, A., Malik, Z., & Parkman, H. P. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1645594 · Cited by 83
Adams, R. L., & Broughton, K. S. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000448665 · Cited by 82
Brown rice compared to white rice slows gastric emptying in humans
Pletsch, E. A., & Hamaker, B. R. (2017) · European Journal of Clinical Nutrition · doi:10.1038/s41430-017-0003-z · Cited by 90
Kocaman, N., & Kuloğlu, T. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101397 · Cited by 86
Dietary Fiber, Gastric Emptying, and Carbohydrate Digestion: A Mini‐Review
Qi, X., Al‐Ghazzewi, F. H., & Tester, R. F. (2018) · Starch - Stärke · doi:10.1002/star.201700346 · Cited by 88
Biological factors controlling starch digestibility in human digestive system
Li, C., Hu, Y., Li, S., Yi, X., Shao, S., Yu, W., & Li, E. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.037 · Cited by 82
Madsbad, S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.019 · Cited by 84
Pathomthongtaweechai, N., & Muanprasat, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060887 · Cited by 86
Ma, J., Jesudason, D. R., Stevens, J. E., Keogh, J. B., Jones, K. L., Clifton, P. M., Horowitz, M., & Rayner, C. K. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.019 · Cited by 71
Self-citationJones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13633 · Cited by 66
Self-citationDPP-4 inhibitors: focus on safety
Tella, S. H., & Rendell, M. S. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.977863 · Cited by 63
The Investigation and Treatment of Diabetic Gastroparesis
Kumar, M., Chapman, A., Javed, S., Alam, U., Malik, R. A., & Azmi, S. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.04.012 · Cited by 68
Xie, C., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090790 · Cited by 67
Self-citationJalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M. (2024) · Endocrinology · doi:10.1210/endocr/bqae155 · Cited by 61
Self-citationGLP-1 based therapies: clinical implications for gastroenterologists
Smits, M. M., van Raalte, D. H., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., & Cahen, D. L. (2016) · Gut · doi:10.1136/gutjnl-2015-310572 · Cited by 61
Chen, S., Zhu, H.-L., & Luo, Y. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00874b · Cited by 61
Marathe, C. S., Rayner, C. K., Bound, M., Checklin, H., Standfield, S., Wishart, J., Lange, K., Jones, K. L., & Horowitz, M. (2014) · Diabetes · doi:10.2337/db13-1757 · Cited by 53
Self-citationMechanisms through which a small protein and lipid preload improves glucose tolerance
Tricò, D., Baldi, S., Tulipani, A., Frascerra, S., Macedo, M. P., Mari, A., Ferrannini, E., & Natali, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3710-9 · Cited by 55
Measurement of gastric emptying in diabetes
Phillips, L. K., Rayner, C. K., Jones, K. L., & Horowitz, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.005 · Cited by 54
Self-citationGIP analogues and the treatment of obesity-diabetes
Bailey, C. J. (2019) · Peptides · doi:10.1016/j.peptides.2019.170202 · Cited by 58
Kinney, G. L., Akturk, H. K., Taylor, D. D., Foster, N. C., & Shah, V. N. (2020) · Diabetes Care · doi:10.2337/dc19-0365 · Cited by 51
Vilarrasa, N., de Gordejuela, A. G. R., Casajoana, A., Duran, X., Toro, S., Espinet, E., Neto, M. G., Vendrell, J. J., López‐Urdiales, R., Pérez, M., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2311-0 · Cited by 51
Petri, M., Singh, I., Baker, C., Underkofler, C., & Rasouli, N. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107733 · Cited by 50
Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
Becker, R. H. A., Stechl, J., Steinstraesser, A., Golor, G., & Pellissier, F. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2647 · Cited by 49
Barrio, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0644 · Cited by 61
Heruc, G. A., Little, T. J., Kohn, M. R., Madden, S., Clarke, S. D., Horowitz, M., & Feinle‐Bisset, C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00149.2018 · Cited by 55
Self-citationMilk in the prevention and management of type 2 diabetes: The potential role of milk proteins
Hidayat, K., Du, X., & Shi, B. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3187 · Cited by 54
Murthy, T. A., Chapple, L. S., Lange, K. M., Marathe, C. S., Horowitz, M., Peake, S., & Chapman, M. J. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac113 · Cited by 57
Self-citationCritical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer
De, S., Banerjee, S., Kumar, S. K. A., & Paira, P. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180423112154 · Cited by 48
Steinert, R. E., Landrock, M. F., Ullrich, S. S., Standfield, S., Otto, B., Horowitz, M., & Feinle‐Bisset, C. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.114488 · Cited by 50
Self-citationOptimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes
Perreault, L., Rodbard, H. W., Valentine, V., & Johnson, E. L. (2019) · Advances in Therapy · doi:10.1007/s12325-018-0868-9 · Cited by 49
Mihai, B. M., Mihai, C., Cijevschi-Prelipcean, C., Grigorescu, E.-D., Dranga, M., Drug, V., Sporea, I., & Lăcătușu, C. M. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1736959 · Cited by 46
“In normal conditions, the rate of gastric emptying may vary between 1 to 4 kcal/min [1], depending on the composition of gastric content (solids or liquids) and the macronutrient type [2].”
BackgroundImpact of Glucose Tolerance Status, Sex, and Body Size on Glucose Absorption Patterns During OGTTs
Færch, K., Pacini, G., Nolan, J. J., Hansen, T., Tura, A., & Vistisen, D. (2013) · Diabetes Care · doi:10.2337/dc13-0592 · Cited by 45
Lu, L., Venn, B., Lu, J., Monro, J., & Rush, E. (2017) · Nutrients · doi:10.3390/nu9050475 · Cited by 51
“, longer chewing time) and swallowing a food bolus with fine particles (<2000 μm) may delay gastric emptying and thus reduce postprandial glycaemia [6,29,31].”
BackgroundThe role of digestive factors in determining glycemic response in a multiethnic Asian population
Tan, V. M. H., Ooi, D. S. Q., Kapur, J., Wu, T., Chan, Y. H., Henry, C. J., & Lee, Y. S. (2016) · European Journal of Nutrition · doi:10.1007/s00394-015-0976-0 · Cited by 44
Nutrients handling after bariatric surgery, the role of gastrointestinal adaptation
Camastra, S., Palumbo, M., & Santini, F. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01194-5 · Cited by 50
The regulation of gastric ghrelin secretion
Nunez‐Salces, M., Li, H., Feinle‐Bisset, C., Young, R. L., & Page, A. J. (2020) · Acta Physiologica · doi:10.1111/apha.13588 · Cited by 49
Lu, L. W., Venn, B., Lu, J., Monro, J., & Rush, E. (2017) · doi:10.20944/preprints201704.0092.v1 · Cited by 44
Nielsen, R., Jorsal, A., Iversen, P., Tolbod, L. P., Bouchelouche, K., Sørensen, J., Harms, H. J., Flyvbjerg, A., Tarnow, L., Kistorp, C., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1000-2 · Cited by 43
Wismann, P., Pedersen, S. L., Hansen, G., Mannerstedt, K., Pedersen, P. J., Jeppesen, P. B., Vrang, N., Fosgerau, K., & Jelsing, J. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.03.004 · Cited by 43
Steinert, R., Raederstorff, D., & Wolever, T. (2016) · Nutrients · doi:10.3390/nu8090524 · Cited by 43
Zhou, L., Yang, Y., Yang, L., Cao, W. J., Jing, H., Xu, Y. J., Jiang, X., Xu, D., Xiao, Q., Jiang, C., et al. (2019) · BMC Anesthesiology · doi:10.1186/s12871-019-0848-x · Cited by 50
Medication-Induced Gastroparesis: A Case Report
Kalas, M. A., Galura, G. M., & McCallum, R. W. (2021) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096211051919 · Cited by 40
Frandsen, C. S., Dejgaard, T. F., Andersen, H. U., Holst, J. J., Hartmann, B., Thorsteinsson, B., & Madsbad, S. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12830 · Cited by 40
Gut mechanisms linking intestinal sweet sensing to glycemic control
Kreuch, D., Keating, D. J., Wu, T., Horowitz, M., Rayner, C. K., & Young, R. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00741 · Cited by 40
“In the majority of patients with type 2 diabetes, who are relatively wellcontrolled, postprandial glycaemic excursions predominate over fasting blood glucose levels in contributing to HbA1c (62), and are determined by meal composition, the rate of gastric emptying, hepatic and peripheral glucose metabolism, intestinal…”
BackgroundSelf-citationBiopolymer interactions during gastric digestion: Implications for nutrient delivery
Acevedo-Fani, A., & Singh, H. (2021) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2021.106644 · Cited by 42
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Miñambres, I., & Pérez, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0204-6 · Cited by 39
“This difference in the effects on gastric emptying between short and long-acting GLP-1 receptor agonists can be attributed to tachyphylaxis, which occurs when stimulation of the receptor is constant—as is the case with longacting agonists—but not when stimulation is intermittent [23].”
BackgroundPapakonstantinou, E., Kontogianni, M. D., Mitrou, P., Magriplis, E., Vassiliadi, D., Nomikos, T., Lambadiari, V., Georgousopoulou, E., & Dimitriadis, G. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.03.008 · Cited by 39
Tricò, D., Galderisi, A., Mari, A., Santoro, N., & Caprio, S. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13640 · Cited by 42
Feunteun, S. L., Al-Razaz, A., Dekker, M., George, E., Laroche, B., & van Aken, G. A. (2021) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-070620-124140 · Cited by 51
Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review
Østergaard, L., Frandsen, C. S., & Madsbad, S. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1121808 · Cited by 38
“short-acting agents can be explained by the lowering of postprandial hyperglycemia due to a more consistent effect on the slowing of gastric emptying.[6,112] As”
BackgroundWeber, M., Siddarthan, I., & Mack, P. F. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.05.005 · Cited by 38
Klair, N., Patel, U. P., Saxena, A., Patel, D. N., Ayesha, I. E., Monson, N. R., & Ramphall, S. (2023) · Cureus · doi:10.7759/cureus.46197 · Cited by 61
Gastrointestinal autonomic neuropathy in diabetes
Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102718 · Cited by 38
Self-citationRezaie, P., Bitarafan, V., Horowitz, M., & Feinle‐Bisset, C. (2021) · Nutrients · doi:10.3390/nu13041317 · Cited by 42
Self-citationMalm-Erjefält, M., Ekblom, M., Vouis, J., Zdravkovic, M., & Lennernäs, H. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00278 · Cited by 36
Wysham, C., Rosenstock, J., Vetter, M. L., Dong, F., Öhman, P., & Iqbal, N. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13056 · Cited by 38
Bozzetto, L., Alderisio, A., Clemente, G., Giorgini, M., Barone, F., Griffo, E., Costabile, G., Vetrani, C., Cipriano, P., Giacco, A., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.015 · Cited by 44
Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1
Plummer, M. P., Jones, K. L., Cousins, C. E., Trahair, L. G., Meier, J. J., Chapman, M. J., Horowitz, M., & Deane, A. M. (2015) · Diabetes Care · doi:10.2337/dc14-3091 · Cited by 36
Self-citationEffect of soy protein isolate preload on postprandial glycemic control in healthy humans
Kashima, H., Uemoto, S., Eguchi, K., Endo, M. Y., Miura, A., Kobayashi, T., & Fukuba, Y. (2016) · Nutrition · doi:10.1016/j.nut.2016.02.014 · Cited by 43
Gopirajah, R., Raichurkar, K. P., Wadhwa, R. P., & Anandharamakrishnan, C. (2016) · Food & Function · doi:10.1039/c6fo00659k · Cited by 36
Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners
Shibib, L., Al-Qaisi, M., Guess, N. D., Miras, A. D., Greenwald, S. E., Pelling, M., & Ahmed, A. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s458894 · Cited by 48
The use of stable isotopes in the study of human pathophysiology
Charidemou, E., Ashmore, T., & Griffin, J. L. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.012 · Cited by 38
The role of whey protein in postprandial glycaemic control
Stevenson, E., & Allerton, D. M. (2017) · Proceedings of The Nutrition Society · doi:10.1017/s0029665117002002 · Cited by 36
Sloop, K. W., Briere, D. A., Emmerson, P. J., & Willard, F. S. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00009 · Cited by 31
Hypoglycaemia and gastric emptying
Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13570 · Cited by 32
Self-citation
Metadata
- Authors
- Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- Corresponding author
- Horowitz, Michael
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1396-1405
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631884
- OpenAlex
- W2162836078
- Cited by
- 335
- References
- 76
- Citations by year
- 2026: 28 · 2025: 15 · 2024: 25 · 2023: 22 · 2022: 28 · 2021: 26 · 2020: 27 · 2019: 33 · 2018: 28 · 2017: 28 · 2016: 36 · 2015: 21 · 2014: 12 · 2013: 6
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gastric emptying, postprandial blood glucose, incretins, glycemic control, HbA1c, type 2 diabetes, glycemic excursions
- MeSH terms
- Blood Glucose, Gastric Emptying, Humans, Models, Biological, Postprandial Period, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.